Qiagen, Bill & Melinda Gates Foundation, Grand Challenges Canada diagnostic news

Qiagen joined the Point-of-Care Diagnostics Initiative to develop an easy-to-use, portable molecular testing device that can perform diagnostic tests in the field, away from hospitals or laboratory infrastructure. The biotech also will create corresponding assay technology for use in low-resource settings. Qiagen expects to complete development by 2014. Qiagen's project is part of the technology development phase of the Point-of-Care Diagnostics initiative, which will then integrate successful technologies into a multifunctional point-of-care platform. ...